Cancercompass News: prostate cancerCancerCompass is an online community committed to offering people living with cancer a place to receive cancer information and news, share knowledge, and share cancer treatment experiences. To learn more, visit our site today.Aureon Laboratories Introduces Prostate Px+, First Biopsy-based Test To Predict Prostate Cancer Disease Progression And Recurrence- June 3, 2008 Aureon Laboratories, Inc., a specialized laboratory dedicated to advancing personalized cancer treatment through predictive pathology, announced the introduction of Prostate Px(R)+, the first commercial test to predict prostate cancer progression and disease recurrence at the time of diagnosis. The announcement was made at the American Urological Association Annual Meeting, now underway at the Orange County Convention Center in Orlando (Booth 505). According to the National Prostate Cancer...http://www.cancercompass.com/cancer-news/1,14286,00.htm?rss=y |